Lead Product(s) : Apricoxib,QS-21 Stimulon
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Agenus
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the collaboration with Targovax, Agenus will supply QS-21 STIMULON and scientific support for up to three initial TG01 clinical trials in different cancer indications.
Product Name : TG01
Product Type : Vaccine
Upfront Cash : Undisclosed
July 03, 2022
Lead Product(s) : Apricoxib,QS-21 Stimulon
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Agenus
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Lion TCR
Deal Size : Undisclosed
Deal Type : Collaboration
Zelluna Collaborates with Lion TCR to Develop TCR-NK Cell Therapies to Treat Virally Induced Cancers
Details : The collaboration will initially focus on the development of TCR-NK products targeting Hepatitis B Virus (HBV) which is a leading cause of liver cancer and has a high unmet need for efficient treatment options.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 24, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Lion TCR
Deal Size : Undisclosed
Deal Type : Collaboration